Stay updated on Tagraxofusp in Secondary AML Clinical Trial
Sign up to get notified when there's something new on the Tagraxofusp in Secondary AML Clinical Trial page.

Latest updates to the Tagraxofusp in Secondary AML Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded Check who can join and Find Contact Information, plus a Revision: v3.6.0 note in the history view. These updates reflect UI and documentation changes that improve access to recruitment information and staff contact details, while recording the latest platform release.SummaryDifference0.4%

- Check19 days agoChange DetectedAn updated revision tag has been added to the history, changing from v3.5.4 to v3.5.5 to reflect an administrative update to the record. This change does not affect the study content or functionality, but records the latest version of the record in ClinicalTrials.gov history.SummaryDifference0.1%

- Check33 days agoChange DetectedA new version entry was added to the study record history, including updated study status entries and refreshed contacts/locations. This reflects ongoing administrative and recruitment updates to the trial.SummaryDifference0.1%

- Check41 days agoChange DetectedThe Record History now includes a new latest revision entry (v3.5.4) and removes the previous revision (v3.5.3) from the history list.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page’s revision identifier changes from **v3.5.2** to **v3.5.3**, indicating an update to the record-history page tooling/label rather than a modification of the clinical trial’s record details.SummaryDifference0.1%

- Check70 days agoChange DetectedA new revision entry v3.5.2 was added to the history, replacing the prior v3.5.0. The previous revision v3.5.0 was removed.SummaryDifference0.1%

Stay in the know with updates to Tagraxofusp in Secondary AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tagraxofusp in Secondary AML Clinical Trial page.